2021
A new cure model accounting for extra non-cancer mortality: Validation and application to real data
Botta L, Goungounga J, Capocaccia R, Romain G, Colonna M, Gatta G, Boussari O, Jooste V. A new cure model accounting for extra non-cancer mortality: Validation and application to real data. Revue D'Epidémiologie Et De Santé Publique 2021, 69: s24. DOI: 10.1016/j.respe.2021.04.039.Peer-Reviewed Original ResearchRelative riskGeneral populationCancer-specific deathNon-cancer mortalityPatient's relative riskExtra riskCancer survivorsCancer patientsCure modelBreast cancerNet survivalRelative survivalOverall populationIndividual data analysisIndividual dataSame riskCure fractionCancer dataDeathPatientsRiskCancerMortalitySurvivalAge effects
2020
Modeling Excess Hazard with Time-to-Cure as a Parameter
Boussari O, Bordes L, Romain G, Colonna M, Bossard N, Remontet L, Jooste V. Modeling Excess Hazard with Time-to-Cure as a Parameter. Biometrics 2020, 77: 1289-1302. PMID: 32869288, DOI: 10.1111/biom.13361.Peer-Reviewed Original ResearchConceptsBeta probability distribution functionProbability distribution functionCure modelNon-mixture cure modelMaximum likelihood approachLikelihood approachDistribution functionIllustrative applicationParticular caseExcess hazard regression modelsPossible extensionsCure fractionSimulation studyEvent of interestCancer data setsData setsParametersModelBetter performanceEstimationRegression models
2018
A new approach to estimate time-to-cure from cancer registries data
Boussari O, Romain G, Remontet L, Bossard N, Mounier M, Bouvier A, Binquet C, Colonna M, Jooste V. A new approach to estimate time-to-cure from cancer registries data. Cancer Epidemiology 2018, 53: 72-80. PMID: 29414635, DOI: 10.1016/j.canep.2018.01.013.Peer-Reviewed Original ResearchConceptsPopulation-based cancer dataFlexible parametric cure modelsThyroid cancer patientsCancer registry dataParametric cure modelsCancer RegistryColorectal cancerCancer patientsPancreatic cancerCancer sitesBreast cancerRegistry dataCure modelAge groupsCancerCureDiagnosisSurvival frameworkCure fractionPatientsHealth insurance premiumsFrench networkSurvival time distributionYears